Get SVHI Updates: Event details, upcoming speakers, live streaming video and more Sign Up!

July 11th, 2026 Meeting (ZOOM): “Hyperbaric Oxygen: its use and How it Helps with Dr. Paul Harch

July 11th, 2026 Meeting (ZOOM): “Hyperbaric Oxygen: its use and How it Helps with Dr. Paul Harch

Posted · Add Comment

Main Presentation: “Hyperbaric Oxygen: Its Use and How It Helps” with Dr. Paul Harch

July 11th, 2025 @ 9am PST

This presentation will discuss hyperbaric oxygen and what conditions it helps with.  He will discuss its history and the use of soft chambers, an how you can find this treatment.   You can learn about it and ask your questions.

Join Zoom Meeting
Meeting ID: 869 0860 6457
Passcode: 824014
One tap mobile
+16699006833,,86908606457#,,,,*824014# US (San Jose)
+16694449171,,86908606457#,,,,*824014# US

 

About Dr. Harch
Paul G. Harch, M.D. is an emergency medicine and hyperbaric medicine clinician and researcher who is a Clinical Professor of Medicine, Section of Emergency Medicine, at LSU School of Medicine, New Orleans, and former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship. His career in hyperbaric medicine was stimulated by a discovery in 1989, assisted by a recommendation for treatment by Dr. Richard Neubauer, that cerebral DCI was treatable long-after the accepted limit of 24h. This finding was coupled with HBOT-induced neurological improvement in boxers with dementia pugulistica (in a 1989 study by colleagues Dr. Keith Van Meter and Sheldon Gottlieb) and a two-year old drowned child. Convergence of these events led to an off-label extension of HBOT to patients with other chronic neurological disorders, animal research, clinical research, and the first treatment of neurological patients with a wide range of disorders, including TBI, dementia, CP, pediatric and adult HIE, toxic brain injury, PTSD, and genetic disorders. Included was the first application to veterans with TBI and PTSD. Currently, he is focused on further development of individual HBOT dosing techniques for neurological disorders and establishing HB

Leave a Reply

Your email address will not be published. Required fields are marked *